![Photo of a brain in a lab](https://www.neurology.columbia.edu/sites/default/files/styles/cola_media_200_21_9/public/media/images/2022-07/brain-bank-2-newsroom-post_2.jpg?itok=wxILykju 200w, https://www.neurology.columbia.edu/sites/default/files/styles/cola_media_260_21_9/public/media/images/2022-07/brain-bank-2-newsroom-post_2.jpg?itok=OignNGh_ 260w, https://www.neurology.columbia.edu/sites/default/files/styles/cola_media_320_21_9/public/media/images/2022-07/brain-bank-2-newsroom-post_2.jpg?itok=P-w25jQp 320w, https://www.neurology.columbia.edu/sites/default/files/styles/cola_media_400_21_9/public/media/images/2022-07/brain-bank-2-newsroom-post_2.jpg?itok=PYOW0gZv 400w, https://www.neurology.columbia.edu/sites/default/files/styles/cola_media_520_21_9/public/media/images/2022-07/brain-bank-2-newsroom-post_2.jpg?itok=iYFGcInk 520w, https://www.neurology.columbia.edu/sites/default/files/styles/cola_media_640_21_9/public/media/images/2022-07/brain-bank-2-newsroom-post_2.jpg?itok=BiaNjljJ 640w, https://www.neurology.columbia.edu/sites/default/files/styles/cola_media_800_21_9/public/media/images/2022-07/brain-bank-2-newsroom-post_2.jpg?itok=UVrhkbTp 800w, https://www.neurology.columbia.edu/sites/default/files/styles/cola_media_1040_21_9/public/media/images/2022-07/brain-bank-2-newsroom-post_2.jpg?itok=I9V5pn9u 1040w, https://www.neurology.columbia.edu/sites/default/files/styles/cola_media_1280_21_9/public/media/images/2022-07/brain-bank-2-newsroom-post_2.jpg?itok=Cln-EOM3 1280w, https://www.neurology.columbia.edu/sites/default/files/styles/cola_media_1600_21_9/public/media/images/2022-07/brain-bank-2-newsroom-post_2.jpg?itok=5XTl3abi 1600w)
New Approach to Alzheimer's Treatment
July 5, 2022
Columbia’s Scott Small, MD, has been one of many Alzheimer’s researchers who say it’s time to abandon amyloid-based therapies.
“In the 90s, the idea that amyloid is the trigger of Alzheimer’s was extremely exciting, and there was a sense that we were on the cusp of curing this devastating, horrible disease,” he says. “It was the right idea based on the available evidence, but the evidence has changed.”
That evidence–which Small and other Columbia researchers played pivotal roles in developing over the past 20 years–is pointing to an alternative theory of Alzheimer’s. [read more]
Source: CUIMC Newsroom